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Abstract
Background: Children with SLE are known to have higher fat mass compared to their peers but there are no
published data regarding exercise capacity as measured by cardiovascular endurance and muscle strength. In our
pilot study of ten children with SLE, we sought to examine body composition, cardiovascular endurance, and
isometric muscle strength.
Findings: Ten pediatric SLE patients were studied with a mean age of 15.5 years and 90 % female. Percent body
fat above 30 %, the recommended normal level in adolescent females, were found in 89 % of female subjects and
40 % of all participants had lower than the recommended norms of muscle mass for their age/gender. Subjects
with renal disease were more likely to have low muscle mass compared to those without renal disease (p = 0.03).
Cardiovascular endurance was reported as estimated maximal oxygen consumption (VO2max) during cycle
ergometry. All participants scored in less than fifth percentile for VO2max measurements compared to data from
age and gender matched published norms. Isokinetic muscle strength testing was performed on upper and lower
extremities. Only one participant (male subject) reached goal percentiles for age and gender.
Conclusions: We found significant deficit in body composition, muscle strength and cardiovascular endurance in
the pediatric SLE population compared to reported published norms. Clinicians should consider these data and
focus on exercise programs that can increase aerobic capacity and muscle strength in this high-risk population.
Abbreviations: ACR, American College of Rheumatology; BMI, Body mass index; CAD, Coronary artery disease;
CDC, Centers for disease control and prevention; CV, Cardiovascular; DEXA, Dual energy x-ray absorptiometry;
dsDNA, Double-stranded deoxyribonucleic acid; SD, Standard deviation; SLE, Systemic lupus erythematosus;
SLEDAI, Systemic lupus erythematosus disease activity index scores; VO2 max, Estimated maximal oxygen consumption
Background
Patients with systemic lupus erythematosus (SLE) are
considered to be at higher risk for early atherosclerosis
and coronary artery disease (CAD), independent of
traditional risk factor such as hypertension and smoking
[1–6]. In order to lessen this risk, we encourage our
patients to engage in exercise and physical activity. This
increased activity may also improve overall quality of
life, fatigue, pain, and emotional well-being [7].
SLE patients may experience difficulties when trying to
become more active; for example, adults with SLE are
known to have decreased cardiovascular endurance, lower
muscle strength, and lower lean muscle mass compared to
age-matched controls [8, 9]. Children with SLE are known
to have higher fat mass compared to their peers; lower
lean muscle mass in these children has been associated
with complications such as vertebral fractures [10–14]. In
our pilot study, we sought to examine body composition,
cardiovascular (CV) endurance, and isometric muscle
strength in ten pediatric patients with SLE.
Findings
Subjects
Institutional review board (IRB) approval was obtained.
Guardians were consented and youth were assented for
participation in the study. The participants were recruited
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from consecutive pediatric SLE patients, defined as age
≤18 years at SLE onset, seen at the Johns Hopkins Chil-
dren’s Center. We excluded patients with active arthritis or
active myositis because the participants needed to be able
to pedal without restrictions on the cycle ergometry for as-
sessment of CV endurance. Participants with a past history
of either arthritis or myositis were permitted. Of the 15
consecutive pediatric SLE patients, four had active arthritis
and one had active myositis, leaving ten pediatric SLE pa-
tients in this pilot study. All patients met the American
College of Rheumatology (ACR) criteria for SLE [15, 16].
Measures
At study entry, demographic data including age at en-
rollment, age at lupus diagnosis, gender, and race, were
collected. Clinical and laboratory data were collected at
the participant’s outpatient rheumatology clinic appoint-
ment within 4 weeks of the study visit and were reported
as present if seen at that visit. Systemic lupus erythema-
tosus disease activity index scores (SLEDAI) scores were
calculated based on these data [17].
We assessed perception of physical fitness by asking
participants about their daily physical activity and
whether they would consider themselves physically ac-
tive over the past year. We assessed the duration in mi-
nutes for each physical activity per week, not including
required school gym participation.
Total body lean and fat mass were assessed by assessed
by dual energy X-ray absorptiometry (DEXA) (GE Lunar
Prodigy, Software V. 13). Body weight and height were ob-
tained by measurement at the time of the study visit. Pa-
tients were divided into age-adjusted categories for
overweight and obese. Definitions for normal ranges of
BMI were per the Centers for Disease Control and Preven-
tion (CDC) guidelines: normal; <85th percentile; overweight,
85–95th percentile; obese, >95th percentile. The CDC rec-
ommended levels for adolescents are <30 % of total body
composition body fat and >60 % lean muscle mass.
CV endurance capacity was assessed using peak oxygen
uptake (VO2 peak) during cycle ergometry. A Cardinal
Health Vmax metabolic system was used to assess oxygen
uptake while the participants pedaled on the stationary bi-
cycle. The initial workload was set at 0 W and was in-
creased by 20 W every 3 min until participants noted
fatigue. Normal values were obtained from published ref-
erence data in adolescents and varied based on age and
gender of the comparative SLE participant [18–21].
A Biodex unit was used to measure isometric muscle
strength using peak isokinetic torques of elbow extension
and flexion at 60 and 120 degrees/second, adjusted for
body weight. Normative elbow values were obtained from
reference data published by Biodex and ranged from 23 to
30 % peak torque/body weight for 60 degrees/second and
13–24 % peak torque/body weight for 120 degrees/second.
Knee peak isokinetic torques were obtained at 60 and 180
degrees/second. Normal knee ranges were 80–95 % peak
torque/body weight for 60 degrees/second movement and
50–65 % peak torque/body weight for 180 degrees/second
movement.
Statistical analyses
We performed two-sided, unpaired t-tests for compari-
son of means and Fisher’s exact tests for comparison of
groups between our cohort and published reference data
for categorical body composition data, continuous CV
endurance data, and continuous muscle strength data
[18, 20, 22]. Simple linear regression analyses were used
to determine predictors of body composition and CV
endurance via VO2 peak during cycle ergometry. We did
not attempt multiple regression for these analyses as
there were too few variables/subjects. Significance levels
were set at a p-value <0.05.
Results
Demographic characteristics are shown in Table 1. Self-
reported physical activity was high in our cohort. Eighty
percent of patients reported that they would consider
themselves physically active over the past year. Sixty
Table 1 Patient characteristics at study entry
Characteristic Value
Age, mean (SD) 15.5 (3.1)
Female gender, n (%) 9 (90 %)
African American, n (%) 8 (80 %)
Mean years with SLE, (SD) 4.2 (2.3)
Malar rash, n (%) 6 (60 %)
Kidney disease, n (%) 5 (50 %)
Focal proliferative, n (%) 1 (10 %)
Membranous, n (%) 1 (10 %)
Diffuse proliferative, n (%) 3 (30 %)
ANA positive, n (%) 10 (100 %)
dsDNA positive, n (%) 9 (90 %)
Ro/La positive, n (%) 2 (20 %)
Smith positive, n (%) 3 (30 %)
Low C3/C4, n (%) 2 (20 %)
Elevated ESR/CRP, n (%) 0 (0 %)
Anemia, n (%) 0 (0 %)
Prednisone 4 (40 %)
Dose 0.1–0.5 mg/kg/day
Duration, mean months, (SD) 2 (3.1)
Hydroxychloroquine, n (%) 10 (100 %)
Methotrexate, n (%) 2 (20 %)
Mycophenolate mofetil, n (%) 4 (40 %)
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percent noted that they participated in physical activity
1–3 days per week for 30–60 min, 20 % participated 4–6
days/week for 0–30 min, and 20 % no exercise.
Fifty percent of participants were above recommended
BMI guidelines. Mean BMI was 23.7 kg/m2 (range 17.1–
31.3 kg/m2). Five subjects had BMI within the normal
Table 2 Body composition by dual energy X-ray absorptiometry (DEXA) scan
Variable ≥30 % Body Fat <30 % Body Fat P-Value ≤60 % Lean Muscle Mass >60 % Lean Muscle Mass P-value
N = 8 N = 2 N = 4 N = 6
Mean Age, years ± Standard
deviation (SD)
16.3 ± 2.7 12.5 ± 3.5 0.4 15.7 ± 4 15.3 ± 2.7 0.8
African American, n 6 2 0.4 4 4 0.2
Years of SLE ± SD 4.1 ± 2.5 4.5 ± 0.7 0.7 3.3 ± 1.6 5.5 ± 2.6 0.2
Physically Active in the
past year
Yes 6 2 0.9 2 6 0.1
No 2 0 2 0
Malar rash
Present 6 0 0.1 4 2 0.07
Absent 2 2 0 4
Kidney Disease
Present 4 1 0.9 4 1 0.04
Absent 4 1 0 5
dsDNA Antibody
Present 8 1 0.2 4 5 0.9
Absent 0 1 0 1
Ro/La Antibodies
Present 2 0 0.9 1 1 0.9
Absent 6 2 3 5
Smith Antibody
Present 3 0 0.9 3 0 0.03
Absent 5 2 1 6
Low C3/C4
Present 2 0 0.9 2 0 0.1
Absent 6 2 2 6
Mean SLEDAI, ± SD 1.3 ± 1.1 0 0.06 2 ± 1.4 0.4 ± 0.2 0.07
Prednisone
Taking 4 0 0.4 3 1 0.1
Not taking 4 2 1 5
Cumulative prednisone
dose, mg (range)
900 (0–3600) 0 0.1 1725 (0–3600) 50 (0–300) 0.1
Hydroxychloroquine
Taking 8 2 – 4 6 –
Not taking
Methotrexate
Taking 2 0 0.9 1 1 0.9
Not taking 6 2 3 5
Mycophenolate mofetil
Taking 3 1 0.9 2 2 0.9
Not taking 5 1 2 4
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range, three were classified as overweight, and two were
obese.
Eighty nine percent of female subjects had a body per-
cent fat above 30 %. Mean body fat percent was elevated
in the entire cohort with a mean of 36.7 % (range in all
9–50.7 %), and mean of 39.7 % in the nine females
(range 25.7–50.7 %). Lean muscle mass ranged from
49.2 to 91 % with a mean of 63.3 %. Forty percent of
participants had lower than 60 % muscle mass for their
age/gender. These same four subjects were also noted to
have elevated body fat (>=30 %). We performed explora-
tory analyses to identify factors associated with abnormal
body composition (Table 2). Participants with renal dis-
ease were more likely to have low muscle mass com-
pared to those without renal disease (p = 0.04). The
presence of Smith antibody was associated with higher
muscle mass (p = 0.03).
CV endurance was reported as estimated maximal
oxygen consumption (VO2max). All participants had
low VO2max measurements compared to data from age
and gender matched normal controls. Eighty percent of
subjects scored at <2nd percentile compared to healthy
controls while the remaining 20 % of SLE subjects scored
between the 2nd and 5th percentile. In regression analysis,
the presence of kidney disease was associated with worse
VO2max measurements (Coef: −10, p = 0.007) (Table 3).
Isometric muscle strength testing was performed on
dominant elbow and knee. In elbow testing, at 60
degrees/second, only one participant reached goal per-
centiles (male subject). All other participants were sig-
nificantly weaker than normal controls, ranging from 10
to 20 % below goal. At 120 degrees/second, none of the
participants reached published goals; however, the
difference between actual to goal results was much
closer (1–10 %). With knee strength testing, no SLE par-
ticipant reached normal goal values (deficit 2–58 % at 60
degrees/second and deficit 10–30 % at 180 degrees/
second).
Conclusions
In this study, we found significant deficits in muscle
strength and CV endurance. These data are in line with
previous studies that have found that adults with SLE
have diminished muscle and aerobic capacity compared
to age-matched controls [8, 9].
Body composition is known to negatively affect quality
of life in SLE. In a study of 202 pediatric SLE patients,
investigators compared health related quality of life be-
tween obese, defined as BMI ≥95th percentile for age
and gender, and non-obese patients [14]. Obese pediatric
SLE patients had significantly worse school function, im-
paired physical function, and significantly more pain/
hurt compared to non-obese pediatric SLE patients and
historical normal controls [14]. In a study of 138 adult
women with SLE, obesity as defined by DEXA scan was
associated with significant cognitive impairment and de-
creased executive function, although the mechanism for
this relationship is not completely clear [23].
Cardiovascular endurance has been measured in adults
with SLE. In 34 women with SLE, lower aerobic capacity
was found in patients compared to controls [9]. There
was no correlation between CV endurance and disease
activity or medications. In our cohort, CV endurance
was significantly decreased, with all of our subjects test-
ing below the 5th percentile of normal children. This low
CV endurance could put children with SLE at increased
risk of cardiovascular disease.
Some participants in our study had normal muscle
mass, but muscle strength was decreased in the majority.
In adults with SLE, both isometric and dynamic muscle
strength has been shown to be decreased compared to
healthy adults. In a study of 146 women with SLE,
muscle mass did not correlate with muscle strength
measurements, and reduced lower extremity muscle
strength was associated with worse self-reported physical
disability [24]. In a longitudinal study of these same
women, muscle measurements were repeated approxi-
mately 2 years apart [25]. Reduced lower extremity
muscle strength predicted clinically significant decreases
in physical function, particular among the weakest sub-
jects. Our findings are particularly worrisome for the
pediatric SLE population as significant deficits in muscle
strength could lead to reduced physical function and
activity.
There are some limitations to our study including
small sample size, cross-sectional analysis, and exclusion
of SLE subjects with active arthritis or myositis. The
Table 3 Regression analysis of cardiovascular endurance
Variable Coefficient P-value
Age, years 0.5 0.5
African American Race −9.7 0.06
Years of SLE 0.2 0.06
Physically Active 7.7 0.2
Malar rash −5.6 0.2
Kidney Disease −10 0.007
dsDNA positive, −11.6 0.1
Ro/La positive −1.5 0.8
Smith positive −9.9 0.02
Low C3/C4 −10.4 0.04
Prednisone −9.1 0.02
Methotrexate −1.5 0.8
Mycophenolate mofetil −6.5 0.1
Body Fat >30 % −5.4 0.3
Muscle mass >60 % 9.7 0.01
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subjects in our cohort had relatively low disease activity
and this may bias our findings, particularly in body com-
position associations. We used published normative
values for control data and this lack of a local compara-
tive group may be a weakness. This is a small sample
size and the regression analyses should be interpreted
with caution and used as hypothesis-generating for
future studies. The strengths of our study include
complete body composition, exercise capacity, and
muscle strength testing data obtained during the same
visit.
Our study reinforced published data of increased body
fat and low muscle mass in pediatric patients with SLE.
Despite low SLE disease activity, the subjects in our co-
hort had significant deficits in CV endurance and muscle
strength. Clinicians should consider focusing on exercise
programs that can increase aerobic capacity in this high-
risk population.
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